Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Amortization of Deferred Charges: 2019

Historic Amortization of Deferred Charges for Agios Pharmaceuticals (AGIO) over the last 1 years, with Dec 2019 value amounting to $8.5 million.

  • Agios Pharmaceuticals' Amortization of Deferred Charges rose 5.01% to $2.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $9.4 million, marking a year-over-year increase of 5.66%. This contributed to the annual value of $8.5 million for FY2019, which is N/A change from last year.
  • Agios Pharmaceuticals' Amortization of Deferred Charges amounted to $8.5 million in FY2019.
  • Agios Pharmaceuticals' 5-year Amortization of Deferred Charges high stood at $8.5 million for FY2019, and its period low was $8.5 million during FY2019.
  • Moreover, its 1-year median value for Amortization of Deferred Charges was $8.5 million (2019), whereas its average is $8.5 million.